Ken Griffin Bioventus Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bioventus Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 37,900 shares of BVS stock, worth $277,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,900
Previous 17,600
115.34%
Holding current value
$277,049
Previous $161,000
55.28%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BVS
# of Institutions
144Shares Held
49.4MCall Options Held
85.1KPut Options Held
13K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$95.2 Million30.91% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$50.7 Million19.48% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.28MShares$38.6 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$20.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$17.3 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $451M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...